Trabectedin not superior to chemotherapy in recurrent epithelial ovarian cancer Presented ByDr Domenica Lorusso, San Raffaele Scientific Institute, Italy TrialPhase 3, MIT023 ConferenceASCO 2022 5 August, 2022 15:25